rethinkPeptides Search
Menu
Home / Research library
Study breakdown

Mapping the GH Secretagogue Receptor in Both Pituitary and Hypothalamus at the Molecular Level

RPEP-004181997McKee, K K; Palyha, O C; Feighner, S D; Hreniuk, D L; Tan, C P; Phillips, M S; Smith, R G; Van der Ploeg, L H; Howard, A D
In VitroModerate evidence
The takeaway

Molecular analysis confirmed GH secretagogue receptors (responding to GHRP-6 and MK-677) exist in both the pituitary and hypothalamus, using a distinct signaling pathway from GHRH.

Dual-site receptor confirmed

GHS receptors molecularly confirmed in both pituitary and hypothalamus, explaining GHRP potency

What the researchers found

GH secretagogue receptors are molecularly confirmed in both pituitary and hypothalamus, using a distinct signal transduction pathway from GHRH.

Why it matters

Confirming receptor expression at two sites explains the potency of GH secretagogues and validates the dual-mechanism model of their action.

How the study worked

Molecular biology analysis of GHS receptor expression in rat pituitary and hypothalamic tissues, characterizing binding and signaling properties.

What this study cannot tell us

Rat tissue analysis; receptor characteristics may differ in humans. In vitro molecular analysis doesn't capture in vivo dynamics.

How to read the evidence

Moderate molecular biology evidence providing definitive receptor characterization in two key tissues.

When this study was published

Published in 1997, contributing to the receptor characterization that preceded ghrelin's discovery.

The bigger picture

This molecular characterization completed the picture of how GH secretagogues work — dual-site action through a unique receptor and pathway.

Questions still open

  • Are hypothalamic and pituitary GHS receptors identical or distinct subtypes?
  • Does GHS receptor density change with age or disease?

Common questions

Why does it matter that the receptor is in two places?
Having receptors in both the hypothalamus and pituitary means GHRPs can stimulate GH release through two independent mechanisms simultaneously — like pressing two buttons at once. This is why GHRPs are so effective.
How is this different from GHRH?
GHRH acts primarily at the pituitary through its own receptor. GH secretagogues act at both the pituitary AND hypothalamus through a completely different receptor. When combined, they activate complementary pathways for a synergistic GH surge.

Read the original research

Molecular analysis of rat pituitary and hypothalamic growth hormone secretagogue receptors.

Molecular endocrinology (Baltimore, Md.), 11(4), 415-23

View on PubMed ↗

Citation

McKee, K K; Palyha, O C; Feighner, S D; Hreniuk, D L; Tan, C P; Phillips, M S; Smith, R G; Van der Ploeg, L H; Howard, A D. (1997). Molecular analysis of rat pituitary and hypothalamic growth hormone secretagogue receptors.. Molecular endocrinology (Baltimore, Md.), 11(4), 415-23.